Figure 4
Figure 4. Increased donor Tcon accumulation within host tissues in recipients of CCR8 −/− Tregs. (A-B) B6D2 recipients were lethally irradiated on day −1 and then administered 3 × 106 TCD BM cells from WT B6 donors plus 1 × 106 column-purified CD4+CD25+ Tregs from WT eGFP– B6 or CCR8−/− eGFP– B6 mice on day 0. Then 4 × 106 CD25-depleted eGFP+ Tcons from WT B6 donors were administered on day +2. Recipient animals were anesthetized on transplant days +14 (A) and day +21 (B), and their organs imaged by fluorescence stereomicroscopy. Total eGFP levels were then quantified in these sites using an eGFP ELISA kit. (A) n = 4 recipients per group. (B) n = 5 recipients per group. *P = .032 for total eGFP comparison between WT and CCR8−/− Treg recipients by the Mann-Whitney test. **P = .016.

Increased donor Tcon accumulation within host tissues in recipients of CCR8 −/− Tregs. (A-B) B6D2 recipients were lethally irradiated on day −1 and then administered 3 × 106 TCD BM cells from WT B6 donors plus 1 × 106 column-purified CD4+CD25+ Tregs from WT eGFP B6 or CCR8−/− eGFP B6 mice on day 0. Then 4 × 106 CD25-depleted eGFP+ Tcons from WT B6 donors were administered on day +2. Recipient animals were anesthetized on transplant days +14 (A) and day +21 (B), and their organs imaged by fluorescence stereomicroscopy. Total eGFP levels were then quantified in these sites using an eGFP ELISA kit. (A) n = 4 recipients per group. (B) n = 5 recipients per group. *P = .032 for total eGFP comparison between WT and CCR8−/− Treg recipients by the Mann-Whitney test. **P = .016.

Close Modal

or Create an Account

Close Modal
Close Modal